Multimodal Neuroimaging Analysis After Mild Traumatic Brain Injury (CHANGE-TBI)

February 22, 2019 updated by: University Hospital, Bordeaux

Cerebral Microstructural and Functional Changes After Single and Repeated Mild Traumatic Brain Injury

Mild Traumatic Brain Injury (mTBI), including concussion, is a real public health problem. Indeed mTBI might induce long-term brain disorders with increased risk of neurodegenerative diseases and the healthcare costs can be significant for both the individual and the society. However mTBI is called the "silent epidemic", because of the lack of research in this field in France as well as in the rest of the world. Most of the time, mTBI is associated with sports injuries, road traffic accidents and falls. The risk of neurodegenerative diseases is significantly increased with the repetition of mTBI, which may have a cumulative effect. In this context, playing football (or 'soccer') is associated with a high risk of concussion and with frequent head-ball contacts which are repeated during the training and matches. Moreover, football is the most popular team sport in the world, with more than 265 million players. The long-term impact of "heading" in football is still debated in the literature. Nevertheless, several studies suggest the possible emergence of early neurocognitive disorders. Otherwise, while mTBI is usually characterized by normal brain images using traditional neuroimaging techniques, microscopic anatomical changes might be detectable by new neuroimaging techniques. According to recent studies, cognitive dysfunctions could be based on these microstructural changes in the gray matter and white matter, secondary to the primary mechanical injury. Studies that have examined the structural changes in the brain white matter in football players are rare and lack of evidence regarding the consequences of accumulated brain impacts explains the lack of preventive measures in this sport. In addition, post-traumatic secondary lesions cause functional alterations of the neurovascular unit and its effect on cerebral perfusion may play a crucial role, which has never been yet explored in humans over the long term.

In this research, the investigators will develop a unique multi-modal neuroimaging protocols to assess brain changes after minor head trauma and over the time. Investigators want to perform magnetic resonance imaging (MRI) to assess cerebral blood flow using Arteria Spin Labelling (ASL), structural changes using Diffusion Tensor Imaging (DTI), susceptibility weighted imaging (SWI), and functional changes using BOLD resting-functional MRI.

Study Overview

Status

Terminated

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France, 33076
        • University Hospital Bordeaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

Applicable to all :

- Male 18 to 25 years, enrolled in French Social Security.

Group of mTBI patients:

- Diagnosis of mTBI in the last 2 weeks confirmed in emergency department of Bordeaux CHU, using the WHO definition (2004): "head trauma ≤ 24h with Glasgow Coma Scale score of 13-15 and with one or more of the three symptoms following: confusion or disorientation, loss of consciousness for 30 minutes or less, posttraumatic amnesia for less than 24h".

Group of footballers:

- Member of the "CFA" and "U19" teams of "Girondins de Bordeaux".

Group of controls:

- Practicing regular physical activity (excluding combat or contact sports).

Exclusion Criteria :

  • Abnormal neurological examination
  • Drug addiction including alcohol Taking drugs targeting the central nervous system History of head trauma, or other notion of central nervous system injury
  • History of severe high blood pressure, diabetes, chronic cardiovascular pathology, progressive or debilitating disease
  • Subject unable to give informed consent
  • Contraindication to MRI: head circumference> 60 - Claustrophobia - Pacemaker, Implantable Neurostimulation, Implantable Defibrillator - Cochlear Implants - Ocular or cerebral ferromagnetic foreign body
  • Refusal to be informed of an abnormality detected during MRI.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brain Magnetic Resonance Imaging (MRI)
Neuroimaging protocol to assess brain changes after minor head trauma and over the time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fractional anisotropy (FA) measure
Time Frame: Month 0
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Month 0
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Time Frame: Month 12
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Month 12
Radial diffusivity (RD) measure
Time Frame: Month 0
Radial diffusivity (RD) measure by Magnetic Resonance Imaging
Month 0
Radial diffusivity (RD) measure
Time Frame: Month 12
Radial diffusivity (RD) measure by Magnetic Resonance Imaging
Month 12
Mean diffusivity (MD) measure
Time Frame: Month 0
Mean diffusivity (MD) measure by Magnetic Resonance Imaging
Month 0
Mean diffusivity (MD) measure
Time Frame: Month 12
Mean diffusivity (MD) measure by Magnetic Resonance Imaging
Month 12
Axial diffusivity (AD) measure
Time Frame: Month 0
Axial diffusivity (AD) measure by Magnetic Resonance Imaging
Month 0
Axial diffusivity (AD) measure
Time Frame: Month 12
Axial diffusivity (AD) measure by Magnetic Resonance Imaging
Month 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain areas on MRI sequences
Time Frame: Month 0
Month 0
Brain areas on MRI sequences
Time Frame: Month 12
Month 12
Brain's white matter injury volume on MRI
Time Frame: Month 0
Month 0
Brain's white matter injury volume on MRI
Time Frame: Month 12
Month 12
Micro-bleedings measure
Time Frame: Month 0
Micro-bleedings measure on MRI in the brain parenchyma
Month 0
Micro-bleedings measure
Time Frame: Month 12
Micro-bleedings measure on MRI in the brain parenchyma
Month 12
Blood brain circulation on MRI
Time Frame: Month 0
Month 0
Blood brain circulation on MRI
Time Frame: Month 12
Month 12
Connectivity modification of on MRI
Time Frame: Month 0
Month 0
Connectivity modification of on MRI
Time Frame: Month 12
Month 12
Actimetry
Time Frame: Month 0
Month 0
Actimetry
Time Frame: Month 12
Month 12
Cognitive performances and emotional state by Ecological Momentary Assessment (EMA)
Time Frame: Month 0
Month 0
Cognitive performances and emotional state by Ecological Momentary Assessment (EMA)
Time Frame: Month 12
Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2016

Primary Completion (Actual)

January 29, 2018

Study Completion (Actual)

January 29, 2018

Study Registration Dates

First Submitted

August 3, 2017

First Submitted That Met QC Criteria

November 9, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

February 26, 2019

Last Update Submitted That Met QC Criteria

February 22, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Traumatic Brain Injury

Clinical Trials on Brain Magnetic Resonance Imaging (MRI)

3
Subscribe